Banned 'wonder drug' creator 'risked patient safety to pocket millions from sale of outlawed medicine made from human blood as a cure for cancer, HIV, multiple sclerosis and autism'

• David Noakes said to have used firm to actively promote products with GcMAF
• Made using human blood, it claims to cure conditions including cancer and HIV
• Is accused of manufacturing, possessing and selling products with ingredient
• He appeared at Southwark Crown Court alongside colleagues and his ex-wife

The creator of a controversial 'wonder drug' made from human blood will stand trial for risking patient safety to pocket millions from the sale of outlawed medicines.

David Noakes, 64, is the CEO and beneficial owner of Immuno Biotech Ltd.

He is said to have used the firm to actively promote products containing GcMAF, made using human blood, by holding it out as a cure for a number of illnesses and conditions including cancer, multiple sclerosis, HIV and autism.

But products containing GcMAF are thought to cause a significant health risk.

Noakes appeared at Southwark Crown Court alongside associate Brian Hall, biochemist Emma Ward and ex-wife and distribution firm director Loraine Noakes.

They denied charges relating to the manufacture, possession and sale of products including the drug.

Noakes also denied money laundering in relation to £7million paid into Immuno's Guernsey bank accounts and a further £2million he raked in personally from sales of GcMAF.

All four will stand trial at the same court next year.

Noakes, of Waldershare, Dover, denied two counts of manufacturing a medicinal product without a manufacturer's licence, two of selling or supplying medicinal products without market authorisation, one of possessing an unauthorised medicinal product without market authorisation and money laundering.

Ward, of Huntingdon, Cambridgeshire, denied two counts of manufacturing a medicinal product without a manufacturer's licence, two of selling or supplying medicinal products without market authorisation and one of possessing an unauthorised medicinal product without market authorisation.

Loraine Noakes, of Ringwood, Hampshire, denied two counts of selling or supplying medicinal products without market authorisation.

Hall, of New Southgate, north London, denied a single count of possessing an unauthorised medicinal product without market authorisation.

Their trial, expected to last up to six weeks, will take place at Southwark Crown Court on 5 November 2018.